Market Cap
349419872.00
TRVI
Trevi Therapeutics, Inc.
Exchange: nyse
Multiples
- P/E: -7.88
- P/BV: 5.00
- P/TBV: 4.23
Description:
TRVI is the ticker symbol for Triumph Therapeutics Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on developing innovative treatments for rare diseases, leveraging its expertise in drug discovery and development to address unmet medical needs. Triumph Therapeutics aims to bring hope to patients suffering from debilitating conditions by advancing its pipeline of therapeutic candidates through clinical trials and regulatory approval processes.
Data:
Yields:
